Southwest Allegheny News

Jul. 22, 2024

HARRISBURG – Rep. Valerie Gaydos (R-Allegheny) applauded the signing of Act 77 of 2024, a new law that aims to address critical issues in the pharmaceutical industry and protect independent pharmacies and their customers. Gaydos was a leader in advancing the bipartisan legislation, along with Rep. Jessica Benham (D-Allegheny).

“This legislation is a crucial step toward ensuring transparency and accountability in how pharmacy benefit managers (PBMs) operate within Pennsylvania,” said Gaydos. “Access to affordable prescription drugs is not just a matter of convenience but a fundamental aspect of health care for millions of Pennsylvanians. As the complexities of health care and medication management continue to evolve, it is essential we act decisively to ensure our pharmacy system operates fairly and transparently for the benefit of all residents.”

PBMs, which negotiate prices and discounts between drug manufacturers, insurers, and pharmacies, have increasingly used practices that have harmed independent pharmacies and the communities they serve. Recent reports indicate Pennsylvania has lost 140 independently owned pharmacies since January, largely due to these practices.

The law implements key reforms aimed at increasing transparency and protecting the interests of patients and independent pharmacies. The law requires the Pennsylvania Insurance Department to establish a process for addressing complaints against PBMs and mandates the disclosure of aggregate rebate data. It also imposes strict regulations to prevent practices that steer patients away from independent pharmacies, bans “clawbacks” where PBMs take back the difference between what insurers pay and what consumers pay, and ensures independent pharmacies receive fair reimbursement within the insurance network.

In addition, the measure expands the scope of practice for pharmacists, pharmacy interns, and pharmacy technicians, enabling them to deliver more vaccines and administer tests for Respiratory Syncytial Virus (RSV), strep, flu, and COVID-19.

“I am proud to see this bipartisan legislation reach the finish line,” said Gaydos. “This law signifies our dedication to fostering a health care environment that upholds patient welfare and supports our local pharmacies, which are vital to our communities. I look forward to seeing the positive impact of these reforms when the law takes effect this fall.”

For more information on Act 77 of 2024, visit Gaydos’ official website at RepGaydos.com or contact her office at 412-262-3780.

Representative Valerie Gaydos

44th Legislative District

Pennsylvania House of Representatives

Media Contact: Rick Leiner

717-260-6437

rleiner@pahousegop.com

RepGaydos.com / Facebook.com/RepGaydos